Vivo Capital Surplus Fund VIII, L.P.
Director at TERN; 10% owner at IMPEL PHARMACEUTICALS INC; 10% owner at BOLT, and 1 more
- Sold, on record
- $5.3M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Dec 19, 2023
- Form 144 notices
- 2
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
- TERNTerns Pharmaceuticals, Inc.Director
- IMPEL PHARMACEUTICALS INC10% owner
- BOLTBolt Biotherapeutics, Inc.10% owner
- CRNXCrinetics Pharmaceuticals, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- IMPEL PHARMACEUTICALS INC575,000 shares
- CRNX330,598 shares
- BOLT86,054 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CRNXUnusualApr 17 2020
Sold 330,598 shares at $15.45 ($5.1M)
Vivo Capital Surplus Fund VIII, L.P., 10% owner
Sold 52.5% of holdings ($9.7M position)298,625 shares leftFirst sale on recordFiling
- 2 Form 4 sale BOLTUnusualNov 20 +1312 days
Sold 86,054 shares at $0.93 ($80k)
Vivo Capital Surplus Fund VIII, L.P., 10% owner
No 10b5-1 planSold 43.2% of holdings ($185k position)113,119 shares leftFirst sale on recordFiling
- 3 Form 4 sale IMPEL PHARMACEUTICALS INCUnusualDec 19 +29 days
Sold 575,000 shares at $0.13 ($74k)
Vivo Capital Surplus Fund VIII, L.P., 10% owner
No 10b5-1 planSold 67.2% of holdings ($110k position)280,294 shares leftFirst sale on recordFiling
- 4 Form 144 notice TERNNoticeApr 1 +104 days
Filed to sell 8,832 shares ($67k)
Vivo Capital Surplus Fund VIII, L.P., Director
10b5-1 planFirst sale on recordFiling
- 5 Form 144 notice TERNNoticeApr 3 +2 days
Filed to sell 5,443 shares ($33k)
Vivo Capital Surplus Fund VIII, L.P., Director
10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 | TERN | Director | Form 144 notice | 5,443 | $33k | Notice | SEC | |
| Apr 1, 2024 | TERN | Director | Form 144 notice | 8,832 | $67k | Notice | SEC | |
| Dec 19, 2023 | IMPEL PHARMACEUTICALS INC | 10% owner | Form 4 sale | 575,000 | $74k | 67.2% | Unusual | SEC |
| Nov 20, 2023 | BOLT | 10% owner | Form 4 sale | 86,054 | $80k | 43.2% | Unusual | SEC |
| Apr 17, 2020 | CRNX | 10% owner | Form 4 sale | 330,598 | $5.1M | 52.5% | Unusual | SEC |